Nitrates III pp 521-527 | Cite as

Renal Changes in Low Cardiac Output Failure: Improvement with Vasodilators

  • J. A. Mantle
  • R. O. RussellJr.
  • W. N. Tauxe
  • H. P. Dustan
  • W. J. Rogers
  • C. E. Rackley
Conference paper


The renal retention of sodium is a major clinical problem in the syndrome of congestive heart failure. Both experimental and clinical studies have demonstrated that the abnormally low urinary excretion of sodium results from a reflex vasoconstriction of the renal vascular bed [2, 3, 8]. Our earlier clinical studies of isosorbide dinitrate in patients with acute myocardial infarction and heart failure demonstrated a significant synergistic effect with furosemide in patients who were oliguric [5]. In order to investigate the mechanisms responsible for these clinical observations, we undertook a perspective study of renal function and the response to vasodilators in patients with congestive heart failure [6].


Urea Creatinine Titration Catecholamine Cardiol 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cogan JJ, Humphreys MH, Carlson CJ, Rapaport E (1980) Renal effects of nitroprusside and hydralazine in patients with congestive heart failure. Circulation 61: 316–323PubMedGoogle Scholar
  2. 2.
    Katholi RE, Oparil S, Urthaler F, James TN (1979) Mechanism of post-arrhythmic renal vasoconstriction in the anesthetized dog. J Clin Invest 64: 17–31PubMedCrossRefGoogle Scholar
  3. 3.
    Kilcoyne MM, Schmidt DH, Cannon PJ (1973) Intrarenal blood flow in congestive heart failure. Circulation 47: 786–797PubMedGoogle Scholar
  4. 4.
    Magrini F, Niarchos AP (1980) Ineffectiveness of sublingual nitroglycerine in acute left ventricular failure in the presence of massive peripheral edema. Am J Cardiol 45: 841–847PubMedCrossRefGoogle Scholar
  5. 5.
    Mantle JA, Russell RO, JR, Moraski RE, Rackley CE (1976) Isosorbide dinitrate for the relief of severe heart failure following myocardial infarction. Am J Cardiol 37: 263–268PubMedCrossRefGoogle Scholar
  6. 6.
    Mantle JA, Russell RO Jr, Tauxe WN, Dustan HP, Rogers WJ, Rackley CE (1979) Altered renal function in heart failure: Effects of vasodilators. Circulation 60: 128Google Scholar
  7. 7.
    Pierpont GL, Brown DC, Franciosa JA, Cohn JN (1980) Effect of hydralazine on renal failure in patients with congestive heart failure. Circulation 61: 323–327PubMedGoogle Scholar
  8. 8.
    Sparks HV, Kopald HH, Carriere S, Chemasky JE, Kinoshita M, Barger AC (1972) Intrarenal distribution of blood flow with chronic congestive heart failure. Am J Physiol 223: 840–846PubMedGoogle Scholar
  9. 9.
    Tauxe WN, Maher FT, Taylor WF (1971) Effective renal plasma flow: Estimation from theoretical volumes of distribution of intravenously injected I131-orthoiodohippurate. Mayo Clin Proc 46: 524–531PubMedGoogle Scholar
  10. 10.
    Walkins L Jr, Burton JA, Haber E, Cont JR, Smith FW, Barger AC (1976) The reninangiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57: 1606–1617CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • J. A. Mantle
  • R. O. RussellJr.
  • W. N. Tauxe
  • H. P. Dustan
  • W. J. Rogers
  • C. E. Rackley

There are no affiliations available

Personalised recommendations